APO
Apollo Global Management, Inc.
APO has lower modeled downside risk, despite its lower overall score.
HOOD
Robinhood Markets, Inc.
HOOD has the edge over APO overall, supported by stronger valuation and stronger modeled upside.
APO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| N/A | |
| N/A |
APO's revenue is currently stable, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like APO.
HOOD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
HOOD's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HOOD.
APO PE Valuation
APO has no meaningful PE right now: it lost money over the past year.
HOOD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 30x | $81.35 | — |
| Cheap | 37x | $78.84 | -3.1% |
| Current | 38x | $81.35 | — |
| Fair | 51x | $110 | +35% |
| Expensive | 74x | $160 | +96% |
Historical ranges are pointers, not guarantees.
HOOD's PE is in its cheap range at 38x. If earnings grow as analysts expect, today's price would be 30x next year's earnings.
APO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for APO, with profitability holding steady.
HOOD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
HOOD has the edge over APO on the outlook, with more favorable profitability expectations.
APO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.14 | — |
| Q3 2026 | -$1.81 | -126% |
| Q2 2026 | $2.75 | -49% |
| Q1 2026 | $1.59 | -72% |
| Q4 2025 | $5.54 | -24% |
| Q3 2025 | $6.86 | -27% |
| Q2 2025 | $5.37 | -42% |
| Q1 2025 | $5.73 | -36% |
| Q4 2024 | $7.33 | -11% |
APO has swung to a loss: it lost $1.81 per share over the past year, after a profit the year before.
HOOD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.72 | +26% |
| Q3 2026 | $2.16 | -10% |
| Q2 2026 | $2.26 | +15% |
| Q1 2026 | $2.06 | +18% |
| Q4 2025 | $2.05 | +31% |
| Q3 2025 | $2.40 | +314% |
| Q2 2025 | $1.96 | +513% |
| Q1 2025 | $1.75 | +1150% |
| Q4 2024 | $1.56 | +$2.17 |
HOOD has the edge over APO on earnings quality, reporting a profit while its opponent remains loss making.
APO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.7B | -52% |
| Q2 2026 | $11.2B | +64% |
| Q1 2026 | $5.1B | -8.8% |
| Q4 2025 | $9.9B | +87% |
| Q3 2025 | $9.8B | +26% |
| Q2 2025 | $6.8B | +13% |
| Q1 2025 | $5.5B | -21% |
| Q4 2024 | $5.3B | -52% |
APO's revenue is growing: $4.7B last quarter, down 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -31% | -60 points |
| Q2 2026 | 22% | +9.9 points |
| Q1 2026 | 5.6% | -16 points |
| Q4 2025 | 18% | -15 points |
| Q3 2025 | 30% | +2.7 points |
| Q2 2025 | 12% | -12 points |
| Q1 2025 | 21% | -9.8 points |
| Q4 2024 | 33% | +15 points |
APO's operating margin was −31% last quarter, down 60 points from the same quarter a year ago.
HOOD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +12% |
| Q2 2026 | $1.3B | +32% |
| Q1 2026 | $1.1B | +15% |
| Q4 2025 | $1.3B | +27% |
| Q3 2025 | $1.3B | +100% |
| Q2 2025 | $989M | +45% |
| Q1 2025 | $927M | +50% |
| Q4 2024 | $1B | +115% |
HOOD has the edge over APO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 44% | -5.9 points |
| Q2 2026 | 54% | +9.5 points |
| Q1 2026 | 39% | -1.5 points |
| Q4 2025 | 52% | -3.5 points |
| Q3 2025 | 50% | +26 points |
| Q2 2025 | 45% | +17 points |
| Q1 2025 | 40% | +14 points |
| Q4 2024 | 55% | +49 points |
HOOD has the edge over APO on profitability, with a higher operating margin.
APO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $136M | -55% |
| Q2 2026 | $2.9B | +128% |
| Q1 2026 | $1.6B | +60% |
| Q4 2025 | $4.7B | +$4.7B |
| Q3 2025 | $303M | -84% |
| Q2 2025 | $1.3B | -5.3% |
| Q1 2025 | $1B | +1346% |
| Q4 2024 | -$4M | -100% |
APO's free cash flow was $9.3B over the past year, about four times what it generated the year before. Free cash flow isn't a meaningful measure for financial services companies like APO.
HOOD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +$2.8B |
| Q2 2026 | $720M | -79% |
| Q1 2026 | $2B | +217% |
| Q4 2025 | -$937M | +$463M |
| Q3 2025 | -$1.6B | -187% |
| Q2 2025 | $3.5B | +6398% |
| Q1 2025 | $642M | +$1.3B |
| Q4 2024 | -$1.4B | -246% |
HOOD has the edge over APO on cash flow, with more consistent year-over-year improvement.
APO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -7.6M shares |
| 1 year | -0.9% | -5.2M shares |
| 3 years | +4.1% | +23.8M shares |
| 5 years | +152% | +363M shares |
| Available history | +170% | +380M shares |
APO has the edge over HOOD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $118M |
| Q2 2026 | $97M |
| Q1 2026 | $632M |
| Q4 2025 | $240M |
| Q3 2025 | $340M |
| Q2 2025 | — |
| Q1 2025 | $193M |
| Q4 2024 | $102M |
APO spent $1.1B buying back its own shares over the past year, up 71% from the year before.
HOOD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -1M shares |
| 1 year | -0.8% | -6.9M shares |
| 3 years | +1.8% | +15.9M shares |
| 5 years | +292% | +679M shares |
| Available history | +7.2% | +60.8M shares |
HOOD has 911M diluted shares, down 0.8% from a year ago, with $789M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25M |
| Q2 2026 | $414M |
| Q1 2026 | $250M |
| Q4 2025 | $100M |
| Q3 2025 | $107M |
| Q2 2025 | $124M |
| Q1 2025 | $322M |
| Q4 2024 | $160M |
HOOD spent $789M buying back its own shares over the past year, up 11% from the year before.
APO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
APO has the edge over HOOD on leverage, with a lower net debt burden relative to earnings.
HOOD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -3.3x | Net Cash |
| Q4 2024 | -3.8x | Net Cash |
HOOD has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like HOOD.
APO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 23.4 | Neutral |
APO's weekly RSI is 49 (neutral) and its Stochastic is 23 (neutral).
HOOD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.8 | Neutral |
| Stochastic | 9.5 | Oversold |
HOOD's weekly RSI is 41 (neutral) and its Stochastic is 10 (oversold).
APO PE vs Financial Services Sector
| Metric | APO | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 13x | 224% above |
| PE % | 85 | 63 | 22 pts above |
APO has no meaningful PE right now: it lost money over the past year.
HOOD PE vs Financial Services Sector
| Metric | HOOD | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 13x | 189% above |
| PE % | 22 | 66 | 44 pts below |
HOOD has the edge over APO on valuation relative to its sector.
APO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $116.5 | 4.2% above |
| 20 week MA | $123.2 | 1.5% below |
| 50 week MA | $126.1 | 3.7% below |
| 100 week MA | $133.4 | 9% below |
| 200 week MA | $116.4 | 4.2% above |
APO has the edge over HOOD on trend strength, trading above more of its moving averages.
HOOD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $97.8 | 17% below |
| 20 week MA | $102.2 | 20% below |
| 50 week MA | $95.4 | 15% below |
| 100 week MA | $88.5 | 8.1% below |
| 200 week MA | $52.1 | 56% above |
HOOD has fallen below most of its moving averages, though it's still 56% above its 200-week average.
APO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.1 | $49.1 | +2.1% |
| 2021 | $49.1 | $74.3 | +51% |
| 2022 | $74.3 | $64.3 | -13% |
| 2023 | $64.3 | $93.2 | +45% |
| 2024 | $93.2 | $170.3 | +83% |
| 2025 | $170.3 | $148.5 | -13% |
| 2026 YTD | $148.5 | $121.4 | -18% |
APO has the edge over HOOD on returns for 2026, with the stronger performance.
HOOD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $35.2 | $18.9 | -46% |
| 2022 | $18.9 | $7.95 | -58% |
| 2023 | $7.95 | $12.7 | +60% |
| 2024 | $12.7 | $39.0 | +206% |
| 2025 | $39.0 | $118.1 | +203% |
| 2026 YTD | $118.1 | $81.4 | -31% |
HOOD's yearly returns have swung widely, from +206% in 2024 to −58% in 2022. It's down 31% so far in 2026.